GO:0060262 negative regulation of N-terminal protein palmitoylation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060262 describes any process that decreases the rate, frequency, or extent of covalent attachment of a palmitoyl group to the N-terminal amino acid residue of a protein.
• N-terminal palmitoylation is a reversible lipid modification that controls membrane anchoring, protein stability, and trafficking of key signaling proteins.
• Mammalian Gup1 (also known as HHATL) acts as a negative regulator of N-terminal palmitoylation of Sonic hedgehog, demonstrating that dedicated enzymes can suppress this modification.
• Phosphorylation near the N-terminus can inhibit palmitoylation, as shown for Arc/Arg3.1 where protein kinase C phosphorylation blocks palmitoylation and nucleic acid interaction.
• Dysregulation of N-terminal palmitoylation is linked to neurodegeneration, cancer, and developmental disorders, making its negative regulation a potential therapeutic target.
• CRISPR knockout, point-mutation, and overexpression models are essential to dissect the causal role of negative regulators such as Gup1/HHATL in palmitoylation-dependent pathways.
Description
Protein palmitoylation is a reversible post-translational lipid modification that attaches a 16-carbon palmitate to cysteine residues, influencing protein-membrane interactions, trafficking, and stability. While most palmitoylation occurs on internal cysteines, a distinct subset of proteins undergoes N-terminal palmitoylation, where the palmitoyl group is added to the alpha-amino group of the N-terminal residue, a modification critical for the function of secreted and membrane-associated proteins. GO:0060262, negative regulation of N-terminal protein palmitoylation, refers to any process that decreases the rate, frequency, or extent of this specific modification. Understanding this regulatory process is important because it provides a layer of control over protein localization and signaling that is distinct from general palmitoylation. Research on N-terminal palmitoylation has revealed that it is not a constitutive event but is subject to active suppression by dedicated enzymes and phosphorylation events. For example, the mammalian homolog of yeast Gup1, HHATL, negatively regulates N-terminal palmitoylation of Sonic hedgehog, thereby affecting Hedgehog signaling during development. Similarly, phosphorylation of Arc/Arg3.1 by protein kinase C inhibits its palmitoylation, highlighting crosstalk between signaling pathways and this modification. These findings underscore the importance of negative regulation in fine-tuning protein function. Dysregulation of N-terminal palmitoylation and its negative regulators has been implicated in human diseases, including neurodegeneration and cancer. For instance, mutations in SPRED1 that impair membrane localization, potentially through altered palmitoylation, cause Legius syndrome, a neurodevelopmental disorder. The tumor suppressor EWI2/PGRL requires palmitoylation for its function, and its differential regulation affects cancer cell behavior. Thus, studying GO:0060262 is essential for understanding disease mechanisms and developing targeted therapies.
negative regulation of N-terminal protein palmitoylation At A Glance
| GO ID | GO:0060262 |
|---|---|
| GO term | negative regulation of N-terminal protein palmitoylation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Decreases the rate, frequency, or extent of covalent attachment of a palmitoyl group to the N-terminal amino acid residue of a protein |
| Related process | Regulation of protein lipidation; regulation of protein membrane targeting |
| Cellular context | Cytosol, endoplasmic reticulum, Golgi apparatus, plasma membrane |
| Example regulator | Mammalian Gup1 (HHATL) acts as a negative regulator of Sonic hedgehog N-terminal palmitoylation |
| Disease relevance | Neurodegeneration, cancer, developmental disorders |
What Is GO:0060262?
GO:0060262, negative regulation of N-terminal protein palmitoylation, is a biological process that encompasses any mechanism that reduces the rate, frequency, or extent of the covalent attachment of a palmitoyl group to the N-terminal amino acid residue of a protein. This definition is based on the QuickGO ontology and reflects a regulatory role that opposes the forward reaction of N-terminal palmitoylation, which is catalyzed by palmitoyltransferases and reversed by thioesterases or inhibited by negative regulators.
Why Is negative regulation of N-terminal protein palmitoylation Important in Cell Biology?
Negative regulation of N-terminal protein palmitoylation is crucial because it provides a dynamic switch to control the membrane association and activity of key signaling proteins. Without such negative regulation, proteins like Sonic hedgehog could be constitutively palmitoylated, leading to aberrant signaling during development. Moreover, phosphorylation-dependent inhibition of palmitoylation, as seen for Arc/Arg3.1, demonstrates how extracellular signals can rapidly modulate this modification to affect synaptic plasticity and gene expression. Dysregulation of these regulatory mechanisms contributes to diseases such as Legius syndrome and cancer, making this process a valuable area of research.
• Controls Sonic hedgehog signaling by regulating its N-terminal palmitoylation, which is essential for proper embryonic development.
• Modulates synaptic function through activity-dependent regulation of PSD-95 and SAP97 N-terminal domains, which govern AMPA receptor trafficking.
• Affects protein stability and localization, as shown for Env7 in yeast where distinct palmitoylation events direct vacuolar fusion.
• Influences viral assembly and infectivity, as the T1 unimolecular spanin requires regulated palmitoylation for proper localization.
• Regulates tumor suppressor function of EWI2/PGRL, where palmitoylation is required for its membrane localization and anti-tumor activity.
• Impacts neurodegeneration through proteins like SPRED1, where mutations affecting membrane localization cause Legius syndrome.
• Provides a mechanism for crosstalk between phosphorylation and lipidation, as shown for Arc/Arg3.1.
• Is a potential therapeutic target for cancers and developmental disorders driven by aberrant Hedgehog signaling.
• Helps maintain proteostasis by preventing inappropriate membrane anchoring of cytosolic proteins.
• Enables fine-tuning of signaling pathways that rely on reversible lipid modifications.
What Happens During negative regulation of N-terminal protein palmitoylation?
Recognition of N-terminal palmitoylation substrates
In simple terms: The cell identifies proteins that are destined to receive a palmitate tag at their very beginning.
Negative regulation begins with the recognition of substrate proteins that undergo N-terminal palmitoylation. These substrates often contain a conserved N-terminal cysteine or a specific motif that is targeted by palmitoyltransferases. For example, Sonic hedgehog is a secreted protein that undergoes N-terminal palmitoylation, and its recognition by the negative regulator Gup1/HHATL prevents this modification. Similarly, the N-terminal domain of PSD-95 and SAP97 contains cysteines that are palmitoylated in an activity-dependent manner, and their regulation involves distinct N-terminal variants. The recognition step may involve direct binding of the negative regulator to the substrate or competition with the palmitoyltransferase.
Enzymatic removal or inhibition of palmitoyl transfer
In simple terms: Enzymes or inhibitors stop the palmitate from being attached to the protein's start.
Once a substrate is recognized, negative regulation can occur through enzymatic removal of the palmitoyl group or by inhibiting the palmitoyltransferase. Mammalian Gup1 acts as a negative regulator of N-terminal palmitoylation of Sonic hedgehog, likely by competing with the palmitoyltransferase HHAT or by facilitating de-palmitoylation. In yeast, Env7 undergoes distinct palmitoylation events at its amino-terminal cysteines, and negative regulation may involve thioesterases that remove the palmitate. Additionally, phosphorylation of Arc/Arg3.1 by protein kinase C inhibits its palmitoylation, suggesting that post-translational modifications can block the transferase active site.
Phosphorylation-dependent inhibition
In simple terms: Adding a phosphate group to the protein can prevent palmitate attachment.
Phosphorylation near the N-terminus can serve as a negative regulatory mechanism. For Arc/Arg3.1, mimicking protein kinase C phosphorylation inhibits its palmitoylation and its interaction with nucleic acids. This suggests that phosphorylation may induce conformational changes that hide the palmitoylation site or disrupt the interaction with the palmitoyltransferase. Similarly, the N-terminal sequence of tyrosine hydroxylase is a conformationally versatile motif that binds 14-3-3 proteins and membranes, and its regulation may involve phosphorylation-dependent changes that affect palmitoylation. Such crosstalk allows extracellular signals to rapidly modulate palmitoylation status.
Consequences for protein localization and function
In simple terms: When palmitate is not added, the protein may not stick to membranes, changing where it works.
The ultimate outcome of negative regulation is altered protein localization and function. For Sonic hedgehog, inhibition of N-terminal palmitoylation by Gup1 affects its signaling activity and distribution. In the case of EWI2/PGRL, palmitoylation is required for its membrane localization and tumor suppressor function, so negative regulation would impair these activities. Similarly, the T1 unimolecular spanin requires regulated palmitoylation for proper localization during viral infection, and its negative regulation could affect viral assembly. Thus, negative regulation of N-terminal palmitoylation serves as a critical switch for protein function.
Key Genes Involved in GO:0060262 negative regulation of N-terminal protein palmitoylation
The following genes and proteins are experimentally implicated in the negative regulation of N-terminal protein palmitoylation or in the modification itself, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HHATL (Gup1) | Negative regulator of N-terminal palmitoylation of Sonic hedgehog | Knockout studies in mammalian cells to assess Hedgehog signaling |
| SPRED1 | Ras regulator; mutations affect membrane localization potentially via palmitoylation | Legius syndrome models; point mutations to study membrane binding |
| PSD-95 | Synaptic scaffold protein with N-terminal palmitoylation | Activity-dependent regulation of AMPA receptors; KO and point mutants |
| SAP97 | Synaptic scaffold protein with alternative N-terminal domains | Studies of synaptic trafficking; domain-specific knockouts |
| ARC (Arg3.1) | Activity-regulated cytoskeleton-associated protein; palmitoylation inhibited by phosphorylation | Point mutations mimicking phosphorylation to block palmitoylation |
| EWI2 (PGRL) | Tumor suppressor requiring palmitoylation for membrane localization | Overexpression and KO in cancer cell lines |
| ENV7 | Yeast protein with N-terminal palmitoylation affecting vacuolar fusion | Yeast genetics; point mutations at cysteine residues |
| T1 spanin | Viral protein requiring palmitoylation for localization | Viral infection models; mutagenesis of palmitoylation sites |
| Tyrosine hydroxylase | Enzyme with N-terminal motif binding 14-3-3 and membranes | Biochemical studies of N-terminal conformation |
| HHAT | Palmitoyltransferase for Sonic hedgehog (opposing negative regulation) | Enzyme assays and inhibitor studies |
| PPT1 | Palmitoyl-protein thioesterase (potential negative regulator) | Neurodegeneration models; KO mice |
| ZDHHC enzymes | Palmitoyltransferases that may be inhibited by negative regulators | Screening for inhibitors; CRISPR KO |
| 14-3-3 proteins | Bind N-terminal motifs and may modulate palmitoylation | Protein interaction studies |
| Protein kinase C | Phosphorylates Arc/Arg3.1 to inhibit palmitoylation | Kinase inhibitors and activators in neurons |
| GUP1 (yeast) | Homolog of HHATL; negative regulator of N-terminal palmitoylation | Yeast genetics and palmitoylation assays |
| PGRL (EWI2) | Immunoglobulin superfamily member with palmitoylation-dependent function | Cancer cell migration assays |
| SPRED1 mutants | Disease-associated variants affecting membrane localization | Knock-in mouse models of Legius syndrome |
How Is negative regulation of N-terminal protein palmitoylation Regulated?
The process of negative regulation of N-terminal protein palmitoylation is itself regulated at multiple levels. Transcription of negative regulators such as HHATL/Gup1 can be controlled by developmental cues, as seen in Hedgehog signaling. Post-translational modifications, particularly phosphorylation, can rapidly inhibit palmitoylation by altering substrate conformation or accessibility, as demonstrated for Arc/Arg3.1. Additionally, the availability of palmitoyl-CoA and the activity of opposing enzymes (palmitoyltransferases and thioesterases) create a dynamic equilibrium that can be shifted by cellular signals. Protein-protein interactions, such as binding of 14-3-3 proteins to N-terminal motifs, may also modulate palmitoylation by sequestering substrates.
negative regulation of N-terminal protein palmitoylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SPRED1 | Legius syndrome; neurodevelopmental disorder | Knock-in mice with patient mutations; neuronal cultures |
| EWI2 (PGRL) | Cancer; tumor suppression | Xenograft models with KO or overexpression |
| HHATL (Gup1) | Developmental disorders; Hedgehog signaling | Zebrafish or mouse KO; cell-based assays |
| ARC (Arg3.1) | Synaptic plasticity; neurodegeneration | Primary neurons with phospho-mimetic mutants |
| PPT1 | Infantile neuronal ceroid lipofuscinosis | KO mice; patient-derived fibroblasts |
Neurodegeneration and Legius syndrome
Mutations in SPRED1 that abolish its membrane localization are associated with Legius syndrome, a neurodevelopmental disorder characterized by café-au-lait spots and learning disabilities. Since SPRED1 membrane targeting may depend on palmitoylation, negative regulation of N-terminal palmitoylation could contribute to disease pathogenesis. Additionally, palmitoyl-protein thioesterase 1 (PPT1) deficiency causes infantile neuronal ceroid lipofuscinosis, a neurodegenerative disorder, highlighting the importance of palmitate turnover in neurons.
Cancer
The tumor suppressor EWI2/PGRL requires palmitoylation for its membrane localization and anti-tumor activity. Negative regulation of its N-terminal palmitoylation could lead to loss of function and promote cancer progression. Furthermore, Hedgehog signaling, which is modulated by N-terminal palmitoylation of Sonic hedgehog, is aberrantly activated in several cancers, and negative regulators such as HHATL may act as tumor suppressors.
Developmental disorders
Proper N-terminal palmitoylation of Sonic hedgehog is essential for embryonic development, and its negative regulation by Gup1/HHATL fine-tunes Hedgehog signaling. Dysregulation of this process can lead to developmental defects, including holoprosencephaly and limb malformations. Additionally, synaptic proteins like PSD-95 and SAP97 rely on regulated palmitoylation for proper neuronal circuit formation, and their misregulation is linked to neurodevelopmental disorders.
From negative regulation of N-terminal protein palmitoylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of HHATL increase N-terminal palmitoylation of Sonic hedgehog? | CRISPR KO in mammalian cells; palmitoylation assays |
| Do Legius syndrome mutations in SPRED1 affect its membrane localization? | Point-mutation knock-in in cell lines; imaging |
| Does phosphorylation of Arc/Arg3.1 inhibit its palmitoylation? | Phospho-mimetic point mutations; neuronal cultures |
| What is the role of Env7 palmitoylation in vacuolar fusion? | Yeast knockouts and point mutants; fluorescence microscopy |
| Can overexpression of EWI2/PGRL suppress tumor growth? | Cancer cell lines and xenografts; overexpression |
| How does the N-terminal domain of tyrosine hydroxylase interact with membranes? | Knock-in of tagged versions; biochemical assays |
How to Study the negative regulation of N-terminal protein palmitoylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Metabolic labeling with [3H]palmitate | Incorporation of palmitate into proteins | Detecting changes in palmitoylation upon KO of negative regulators |
| Click chemistry palmitoylation probes | Labeling of palmitoylated proteins for click detection | Non-radioactive quantification in high-throughput screens |
| Site-directed mutagenesis | Effect of specific residues on palmitoylation | Mapping N-terminal palmitoylation sites |
| CRISPR knock-in of phospho-mimetic mutations | Impact of phosphorylation on palmitoylation | Studying Arc/Arg3.1 regulation |
| Fluorescence microscopy | Subcellular localization of palmitoylated proteins | Assessing membrane targeting of SPRED1 mutants |
| Acyl-biotin exchange (ABE) | Global profiling of palmitoylated proteins | Identifying substrates of negative regulators |
| Co-immunoprecipitation | Protein-protein interactions | Detecting Gup1-substrate complexes |
| Proximity labeling (BioID) | Interactome of negative regulators | Discovering new components of the regulatory machinery |
Palmitoylation assays
The most direct method to study negative regulation of N-terminal palmitoylation is the metabolic labeling of cells with [3H]palmitate, followed by immunoprecipitation and fluorography. This approach has been used to demonstrate that Gup1 negatively regulates Sonic hedgehog palmitoylation. Alternatively, click chemistry-based probes (e.g., 17-ODYA) allow non-radioactive detection and quantification of palmitoylated proteins. These assays can be combined with CRISPR knockout of candidate negative regulators to assess changes in palmitoylation levels.
Site-specific mutagenesis and knock-in
To pinpoint the N-terminal palmitoylation site and its regulation, site-directed mutagenesis of the N-terminal cysteine or adjacent residues is essential. For example, mutating the N-terminal cysteines of Env7 abolished its palmitoylation and altered vacuolar fusion. CRISPR-mediated knock-in of such mutations into the endogenous locus provides more physiologically relevant models. Similarly, phospho-mimetic mutations (e.g., Ser/Thr to Asp) can test the impact of phosphorylation on palmitoylation, as done for Arc/Arg3.1.
Imaging and subcellular localization
Fluorescence microscopy of GFP- or mCherry-tagged proteins can reveal how negative regulation of palmitoylation affects membrane localization. For instance, SPRED1 mutants that fail to localize to the membrane can be visualized in patient-derived cells. Total internal reflection fluorescence (TIRF) microscopy is particularly useful for studying dynamic palmitoylation-dependent membrane association of synaptic proteins like PSD-95. Co-localization with organelle markers helps determine whether the protein is mislocalized to the cytosol or other compartments.
Proteomics and interactomics
Large-scale proteomic approaches, such as acyl-biotin exchange (ABE) or palmitoyl-protein enrichment, can identify the repertoire of N-terminally palmitoylated proteins and how they change upon knockout of negative regulators. Quantitative mass spectrometry can measure palmitoylation stoichiometry. Additionally, interactome studies using proximity labeling (BioID) can uncover proteins that interact with negative regulators like Gup1/HHATL, revealing the molecular machinery involved.
How CRISPR Can Be Used to Study GO:0060262 negative regulation of N-terminal protein palmitoylation
Knockout
CRISPR knockout of negative regulators such as HHATL/Gup1 can be used to assess whether loss of function increases N-terminal palmitoylation of target proteins like Sonic hedgehog. In yeast, knockout of GUP1 leads to hyper-palmitoylation of substrates, providing a powerful genetic model. Similarly, knocking out potential thioesterases or kinases that inhibit palmitoylation can reveal their roles. Knockout cell lines are also useful for generating isogenic controls for drug studies.
Point Mutation
CRISPR-mediated point mutations can mimic disease-associated variants or phospho-mimetic changes. For example, introducing the Legius syndrome mutations into the endogenous SPRED1 locus allows study of their effect on membrane localization and palmitoylation. Point mutations at the N-terminal cysteine of Env7 can abolish palmitoylation and reveal its role in vacuolar fusion. Such precise edits are essential to distinguish between palmitoylation-dependent and independent functions.
Knock-in
Knock-in of tagged versions of proteins (e.g., GFP or HA) at the endogenous locus enables visualization and biochemical analysis of palmitoylation in a physiological context. For instance, knocking in a tag into the N-terminus of tyrosine hydroxylase can help study its conformational changes upon palmitoylation. Knock-in of a palmitoylation-deficient mutant (Cys to Ala) can serve as a negative control. These models are invaluable for studying the dynamics of N-terminal palmitoylation in vivo.
Overexpression
Overexpression of negative regulators such as Gup1/HHATL can suppress N-terminal palmitoylation and downstream signaling. Conversely, overexpression of substrate proteins can overwhelm the regulatory machinery and increase palmitoylation. Overexpression models are useful for gain-of-function studies and for testing whether a candidate gene is sufficient to inhibit palmitoylation. They can be combined with palmitoylation assays to quantify the effect.
How EDITGENE Supports negative regulation of N-terminal protein palmitoylation Research
Researchers studying negative regulation of N-terminal protein palmitoylation-related genes often need to determine whether a candidate gene is causally involved in the modification, how mutations affect protein function, and whether targeting the pathway has therapeutic potential. EDITGENE provides a comprehensive suite of CRISPR services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of N-terminal protein palmitoylation research.
Frequently Asked Questions About negative regulation of N-terminal protein palmitoylation
What is GO:0060262?
GO:0060262 is the Gene Ontology term for negative regulation of N-terminal protein palmitoylation, defined as any process that decreases the rate, frequency, or extent of covalent attachment of a palmitoyl group to the N-terminal amino acid residue of a protein.
What genes are involved in negative regulation of N-terminal protein palmitoylation?
Key genes include HHATL (Gup1), which negatively regulates Sonic hedgehog palmitoylation, SPRED1, which is linked to Legius syndrome, and ARC/Arg3.1, whose palmitoylation is inhibited by phosphorylation.
How does Gup1 regulate Sonic hedgehog palmitoylation?
Mammalian Gup1 (HHATL) acts as a negative regulator by decreasing the N-terminal palmitoylation of Sonic hedgehog, thereby modulating Hedgehog signaling during development.
What diseases are associated with dysregulation of N-terminal palmitoylation?
Dysregulation is linked to Legius syndrome (SPRED1 mutations), cancer (EWI2/PGRL), and developmental disorders due to aberrant Hedgehog signaling.
What methods are used to study negative regulation of N-terminal palmitoylation?
Common methods include metabolic labeling with [3H]palmitate, click chemistry probes, site-directed mutagenesis, CRISPR knockout/knock-in, and fluorescence microscopy.
Can CRISPR be used to study N-terminal palmitoylation?
Yes, CRISPR knockout of negative regulators like HHATL can increase palmitoylation, while knock-in of point mutations can mimic disease variants or phospho-mimetic changes.
What is the role of phosphorylation in N-terminal palmitoylation?
Phosphorylation near the N-terminus can inhibit palmitoylation, as shown for Arc/Arg3.1 where protein kinase C phosphorylation blocks palmitoylation and nucleic acid interaction.
Which proteins undergo N-terminal palmitoylation?
Proteins such as Sonic hedgehog, PSD-95, SAP97, Env7, and EWI2/PGRL undergo N-terminal palmitoylation, which affects their localization and function.
How does N-terminal palmitoylation affect protein function?
It promotes membrane anchoring, influences trafficking, and can regulate protein stability and interactions, as seen for Sonic hedgehog and synaptic proteins.
What are the therapeutic implications of targeting N-terminal palmitoylation?
Modulating negative regulators could offer therapeutic strategies for cancers with aberrant Hedgehog signaling and for neurodegenerative disorders linked to palmitoylation defects.
Conclusion
GO:0060262, negative regulation of N-terminal protein palmitoylation, represents a critical layer of control over a unique lipid modification that impacts development, neuronal function, and disease. The identification of dedicated negative regulators such as Gup1/HHATL and the crosstalk with phosphorylation pathways highlight the complexity of this process. Continued research using CRISPR models and advanced proteomics will further elucidate the mechanisms and therapeutic potential of targeting this pathway. EDITGENE is committed to providing the tools needed to accelerate these discoveries.
References
- 1. Hirata Y et al.. 2024. Legius syndrome mutations in the Ras-regulator SPRED1 abolish its membrane localization and potentially cause neurodegeneration.. J Biol Chem 300(12):107969 PMID: 39510187
- 2. Schlüter OM et al.. 2006. Alternative N-terminal domains of PSD-95 and SAP97 govern activity-dependent regulation of synaptic AMPA receptor function.. Neuron 51(1):99-111 PMID: 16815335
- 3. Abe Y et al.. 2008. Mammalian Gup1, a homolog of Saccharomyces cerevisiae glycerol uptake/transporter 1, acts as a negative regulator for N-terminal palmitoylation of Sonic hedgehog.. FEBS J 275(2):318-31 PMID: 18081866
- 4. Manandhar SP et al.. 2014. Distinct palmitoylation events at the amino-terminal conserved cysteines of Env7 direct its stability, localization, and vacuolar fusion regulation in S. cerevisiae.. J Biol Chem 289(16):11431-11442 PMID: 24610781
- 5. Kongari R et al.. 2018. Localization and Regulation of the T1 Unimolecular Spanin.. J Virol 92(22) PMID: 30135120
- 6. Barylko B et al.. 2024. Mimicking Protein Kinase C Phosphorylation Inhibits Arc/Arg3.1 Palmitoylation and Its Interaction with Nucleic Acids.. Int J Mol Sci 25(2) PMID: 38255853
- 7. He B et al.. 2011. Differential functions of phospholipid binding and palmitoylation of tumour suppressor EWI2/PGRL.. Biochem J 437(3):399-411 PMID: 21609323
- 8. Skjevik AA et al.. 2014. The N-terminal sequence of tyrosine hydroxylase is a conformationally versatile motif that binds 14-3-3 proteins and membranes.. J Mol Biol 426(1):150-68 PMID: 24055376
